These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36711577)

  • 21. CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR.
    Bapat J; Yamamoto TM; Woodruff ER; Qamar L; Mikeska RG; Aird KM; Watson ZL; Brubaker LW; Bitler BG
    Cancer Gene Ther; 2024 Feb; 31(2):300-310. PubMed ID: 38030811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new spontaneously transformed syngeneic model of high-grade serous ovarian cancer with a tumor-initiating cell population.
    McCloskey CW; Goldberg RL; Carter LE; Gamwell LF; Al-Hujaily EM; Collins O; Macdonald EA; Garson K; Daneshmand M; Carmona E; Vanderhyden BC
    Front Oncol; 2014; 4():53. PubMed ID: 24672774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipidome of atherosclerotic plaques from hypercholesterolemic rabbits.
    Bojic LA; McLaren DG; Shah V; Previs SF; Johns DG; Castro-Perez JM
    Int J Mol Sci; 2014 Dec; 15(12):23283-93. PubMed ID: 25517033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long Non-Coding RNA HAND2-AS1 Acts as a Tumor Suppressor in High-Grade Serous Ovarian Carcinoma.
    Gokulnath P; de Cristofaro T; Manipur I; Di Palma T; Soriano AA; Guarracino MR; Zannini M
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 26. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.
    Sherman-Baust CA; Kuhn E; Valle BL; Shih IeM; Kurman RJ; Wang TL; Amano T; Ko MS; Miyoshi I; Araki Y; Lehrmann E; Zhang Y; Becker KG; Morin PJ
    J Pathol; 2014 Jul; 233(3):228-37. PubMed ID: 24652535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma lipidomics in subjects with combat posttraumatic stress disorder.
    Konjevod M; Sáiz J; Nikolac Perkovic M; Nedic Erjavec G; Tudor L; Uzun S; Kozumplik O; Barbas C; Zarkovic N; Pivac N; Strac DS
    Free Radic Biol Med; 2022 Aug; 189():169-177. PubMed ID: 35918015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-grade serous ovarian and fallopian tube carcinomas with similar clinicopathological characteristics might originate from serous tubal intraepithelial carcinoma in Chinese women.
    Wang J; Wu H; Zhang Y; Zhang Y; Li X; Zhao Q; Meng F; Huang Q; Wang Y
    Int J Clin Exp Pathol; 2017; 10(8):8222-8232. PubMed ID: 31966673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis.
    Hada T; Miyamoto M; Ishibashi H; Matsuura H; Kakimoto S; Iwahashi H; Tsuda H; Takano M
    Diagn Pathol; 2022 Jan; 17(1):12. PubMed ID: 35057833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of ovarian cancer cell secretome during epithelial to mesenchymal transition reveals a protein signature associated with advanced stages of ovarian tumors.
    Lanfredi GP; Thomé CH; Ferreira GA; Silvestrini VC; Masson AP; Vargas AP; Grassi ML; Poersch A; Candido Dos Reis FJ; Faça VM
    Biochim Biophys Acta Proteins Proteom; 2021 Jun; 1869(6):140623. PubMed ID: 33607274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spatial Transcriptomics Depict Ligand-Receptor Cross-talk Heterogeneity at the Tumor-Stroma Interface in Long-Term Ovarian Cancer Survivors.
    Ferri-Borgogno S; Zhu Y; Sheng J; Burks JK; Gomez JA; Wong KK; Wong STC; Mok SC
    Cancer Res; 2023 May; 83(9):1503-1516. PubMed ID: 36787106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics.
    Konishi I; Abiko K; Hayashi T; Yamanoi K; Murakami R; Yamaguchi K; Hamanishi J; Baba T; Matsumura N; Mandai M;
    J Gynecol Oncol; 2022 Sep; 33(5):e83. PubMed ID: 36032027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathological study of SET subtype of ovarian high-grade serous carcinoma].
    Sun YW; Shen DH; Cui SS; He HJ; Zhang XL; Wang W; Liu CR
    Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):595-600. PubMed ID: 31550775
    [No Abstract]   [Full Text] [Related]  

  • 35. Incidence of malignant transformation in the oviductal fimbria in laying hens, a preclinical model of spontaneous ovarian cancer.
    Paris EA; Bahr JM; Bitterman P; Basu S; Abramowicz JS; Barua A
    PLoS One; 2021; 16(7):e0255007. PubMed ID: 34314463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway.
    Li Y; Wu T; Wang Y; Yang L; Hu C; Chen L; Wu S
    Gynecol Oncol; 2018 Apr; 149(1):163-172. PubMed ID: 29429592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipidomics Reveals Triacylglycerol Accumulation Due to Impaired Fatty Acid Flux in Opa1-Disrupted Fibroblasts.
    Bocca C; Kane MS; Veyrat-Durebex C; Nzoughet JK; Chao de la Barca JM; Chupin S; Alban J; Procaccio V; Bonneau D; Simard G; Lenaers G; Reynier P; Chevrollier A
    J Proteome Res; 2019 Jul; 18(7):2779-2790. PubMed ID: 31199663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in Nucleolin Expression during Malignant Transformation Leading to Ovarian High-Grade Serous Carcinoma.
    Paris EA; Bahr JM; Basu S; Barua A
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma.
    Akashi H; Yachida N; Ueda H; Yamaguchi M; Yamawaki K; Tamura R; Suda K; Ishiguro T; Adachi S; Nagase Y; Ueda Y; Ueda M; Abiko K; Kagabu M; Baba T; Nakaoka H; Enomoto T; Murai J; Yoshihara K
    Mol Cancer Ther; 2024 Jan; 23(1):106-116. PubMed ID: 37717249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.
    Vang R; Levine DA; Soslow RA; Zaloudek C; Shih IeM; Kurman RJ
    Int J Gynecol Pathol; 2016 Jan; 35(1):48-55. PubMed ID: 26166714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.